医药药品公司错过了Q2收入估计数,报告每股损失0.65美元,11月14日库存为2.20美元。 Medicus Pharma missed Q2 earnings estimates, reporting a $0.65 loss per share, with stock at $2.20 on Nov. 14.

医疗药品(NASDAQ:MDCX)报告第二季度损失每股0.65美元,损失估计数27美元,收入471万美元。 Medicus Pharma (NASDAQ:MDCX) reported a second-quarter loss of $0.65 per share, missing estimates by $0.27, with revenue of $4.71 million. 库存于11月14日以2.20美元关闭,低于50天和200天移动平均数,减少0.06美元。 The stock closed at $2.20 on November 14, down $0.06, below its 50-day and 200-day moving averages. 尽管P/E比率为负数,市场上限为3 920万美元,但分析师仍维持了“机动购买”共识,平均价格目标为23.50美元,尽管一家公司将其目标提高到27.00美元。 Despite a negative P/E ratio and market cap of $39.20 million, analysts maintain a "Moderate Buy" consensus with a $23.50 average price target, though one firm raised its target to $27.00. 该公司继续侧重于推进生物技术部门的新治疗方法。 The company continues to focus on advancing novel therapeutics in the biotech sector.